Form D · Pharmaceuticals
GOLDEN SUNRISE NUTRACEUTICAL INC
Porterville, CA · CIK 0001705521
Offering snapshot reported Jun 20, 2025 · SEC filing
- Reported sold
- Yet to sell Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 20, 2025 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| May 10, 2017 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired, Pooled investment fund
- Exemptions
- 06c
- Duration over one year
- Yes
- Business combination
- Yes
- Sales commissions
- $1M (estimated)
- Finders' fees
- $60K (estimated)
- Form D file number
- 021-549428
Based on Offering and Sales Amounts
In Securities Transactions
Source: Form D, filed Jun 20, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Edgar Ayala | Promoter |
| Rachel M. Ayala | Director |
| Hylton L. Dennis | Executive |
| Martin F. Loeffler | Executive |
| Huu S. Tieu | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
219 North E Street
Porterville, CA, 93257
Phone: 559-781-0658
Porterville, CA, 93257
Phone: 559-781-0658